Ikarian Capital’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 127 |
|
|
2025
Q1 | – | Sell |
-600
| Closed | -$14.9K | – | 146 |
|
|
2024
Q4 | $14.9K | Buy |
+600
| New | +$14.9K | ﹤0.01% | 116 |
|
|
2024
Q3 | – | Sell |
-276,925
| Closed | -$7.31M | – | 116 |
|
|
2024
Q2 | $7.31M | Hold |
276,925
| – | – | 1.27% | 14 |
|
|
2024
Q1 | $8.95M | Buy |
276,925
+43,531
| +19% | +$1.41M | 0.98% | 12 |
|
|
2023
Q4 | $9.83M | Sell |
233,394
-64,400
| -22% | -$2.71M | 0.92% | 13 |
|
|
2023
Q3 | $11.4M | Buy |
+297,794
| New | +$11.4M | 1.38% | 7 |
|
|
2023
Q2 | – | Sell |
-774,398
| Closed | -$12M | – | 103 |
|
|
2023
Q1 | $12M | Sell |
774,398
-192,302
| -20% | -$2.98M | 2.73% | 2 |
|
|
2022
Q4 | $17.2M | Buy |
966,700
+155,000
| +19% | +$2.75M | 4.14% | 2 |
|
|
2022
Q3 | $4.53M | Buy |
+811,700
| New | +$4.53M | 0.9% | 19 |
|
|
2021
Q4 | – | Sell |
-83,046
| Closed | -$722K | – | 166 |
|
|
2021
Q3 | $722K | Sell |
83,046
-102,454
| -55% | -$891K | 0.05% | 110 |
|
|
2021
Q2 | $1.96M | Buy |
+185,500
| New | +$1.96M | 0.16% | 86 |
|
|
2021
Q1 | – | Sell |
-235,587
| Closed | -$10.9M | – | 209 |
|
|
2020
Q4 | $10.9M | Sell |
235,587
-86,300
| -27% | -$3.99M | 0.48% | 14 |
|
|
2020
Q3 | $11.3M | Buy |
321,887
+39,724
| +14% | +$1.4M | 0.82% | 6 |
|
|
2020
Q2 | $6.87M | Sell |
282,163
-560,300
| -67% | -$13.6M | 0.55% | 18 |
|
|
2020
Q1 | $13.1M | Buy |
842,463
+338,346
| +67% | +$5.27M | 0.99% | 5 |
|
|
2019
Q4 | $8M | Buy |
+504,117
| New | +$8M | 1.3% | 3 |
|